Comment on: Thallas-Bonke et al. (2008) Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway: Diabetes 57:460-469, 2008.
Sho-ichi
S
Yamagishi
D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000201:enzymology*; D003928:Diabetic Nephropathies / Q000201:enzymology*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D017127:Glycation End Products, Advanced / Q000037:antagonists & inhibitors*; D019255:NADPH Oxidases / Q000037:antagonists & inhibitors*; D051571:Protein Kinase C-alpha / Q000378:metabolism*; D051381:Rats
D004791:Enzyme Inhibitors; D017127:Glycation End Products, Advanced; D019255:NADPH Oxidases; D051571:Protein Kinase C-alpha